Combined preemptive and preventive analgesia in morbidly obese patients undergoing open gastric bypass: A pilot study.

Author: Kamelgard JI, Kim KA, Atlas G

Author affiliation: Department of Surgery, University Hospital, University of Medicine and Dentistry of New Jersey/New Jersey Medical School, Newark, New Jersey, USA. kamelgard@LighterForLife.com

Publication date & source: 2005.01, Surg Obes Relat Dis., 1(1):12-6.

Publication type: Comparative Study ; Randomized Controlled Trial

PURPOSE: It is difficult to balance adequate pain control against the risk of sedation and depressed breathing in severely obese patients. This study assesses the effects of combined preemptive and preventive analgesia on narcotic use after open gastric bypass. METHODS: Twenty patients were randomized in this prospective double-blind trial comparing preoperative 30 mg intravenous ketorolac (Toradol), 0.25% subcutaneous bupivacaine (Marcaine) with epinephrine along the planned incision, and 0.25% bupivacaine in the rectus fascia before closing with identical injections with 0.9% saline. The patients' self-assessed pain on a visual analogue scale (VAS) and total narcotic use by patient-controlled analgesia (PCA) and rescue medication were recorded. RESULTS: Age, body mass index (BMI), incision length, and operative times were similar between the two groups, as was the average length of hospital stay (2.9 days). Self-reported pain was less in the treatment group 1 hour postoperatively (P = .01). Narcotic use was less in the treatment group during the first 2 hospital days (51% less on day 1 vs 44.5% less on day 2). Total narcotic use during the hospital stay was reduced by 40% (P = .02). CONCLUSIONS: Patients receiving combined preemptive and preventive analgesia used significantly less narcotic pain medication than the patients receiving placebo. The effect lasted beyond the duration of action of the local anesthetic.